Evidence map›Paper›PMID 33553120›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Huilong Fang, Ling Yu, Da You, Nan Peng, Wanbei Guo, Junjie Wang, Xing Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in nutrition · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Huilong FangDepartment of Pharmacology, Xiangnan University, Chenzhou, China.
Ling YuAffiliated Hospital of Xiangnan University, Chenzhou, China.
Da YouDepartment of Pharmacology, Xiangnan University, Chenzhou, China.
Nan PengDepartment of Pharmacology, Xiangnan University, Chenzhou, China.
Wanbei GuoDepartment of Pharmacology, Xiangnan University, Chenzhou, China.
Junjie WangDepartment of Pharmacology, Xiangnan University, Chenzhou, China.
Xing ZhangDepartment of Trauma and Reconstructive Surgery, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen, Germany.
Xiangnan University · CNUniversitätsklinikum Aachen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis has been a fatal obstinate disease that threatens global human health, resulting in the granulomatous inflammation and liver fibrosis.

Indexed as

liver fibrosismadecassosidepraziquantelpro-inflammatory factorsSchistosoma japonicum

Identifiers

PMID33553120
PMCPMC7862569
OpenAlexW3122431135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.